New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar

As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.

👉 Click here to access your FREE report now!

ZLAB Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 13.88%

Insider Buying (Last 12 Months): $119,600.00

Insider Selling (Last 12 Months): $2,125,230.82

Zai Lab Insider Trading History Chart

Zai Lab Share Price & Price History

^$26.23

▲ +0.08 (0.31%)

As of 11/20/2024 01:00 AM ET

Days: 30 | 90 | 365

2025 AI Stock Picks: 2 Hidden Gems Under $10/Share

From Darwin | Ad

The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.

👉[Click here to get your FREE report delivered instantly!]

Zai Lab Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/16/2024	Joshua L. Smiley	Insider	Sell	4,352	$16.67	$72,547.84	43,232
7/1/2024	William Lis	Director	Sell	10,397	$17.32	$180,076.04	53,089
7/1/2024	Ying Du	CEO	Sell	7,013	$17.48	$122,587.24	1,081,910
6/26/2024	Harald Reinhart	Insider	Sell	7,431	$17.90	$133,014.90	62,619
6/26/2024	Yajing Chen	CFO	Sell	2,154	$17.90	$38,556.60	13,714
6/26/2024	Ying Du	CEO	Sell	23,939	$17.90	$428,508.10	1,142,833
5/14/2024	Frazor Titus Edmondson, III	Insider	Sell	10,000	$21.33	$213,300.00	16,408
4/4/2024	Joshua L. Smiley	Insider	Sell	1,988	$15.67	$31,151.96	28,684
4/4/2024	Yajing Chen	CFO	Sell	845	$15.67	$13,241.15	9,618
4/2/2024	Frazor Titus Edmondson, III	Insider	Sell	885	$16.15	$14,292.75	22,621
4/2/2024	Yajing Chen	CFO	Sell	519	$16.15	$8,381.85	7,963
4/2/2024	Ying Du	CEO	Sell	5,787	$16.15	$93,460.05	1,107,972
3/15/2024	Rafael Amado	Insider	Sell	2,544	$18.86	$47,979.84	20,093
1/3/2024	Ying Du	CEO	Sell	8,380	$26.12	$218,885.60	1,133,450
1/2/2024	Rafael Amado	Insider	Sell	19,363	$26.30	$509,246.90	22,637
12/14/2023	Joshua L. Smiley	Insider	Buy	4,000	$29.90	$119,600.00	20,527
11/16/2023	Joshua L. Smiley	Insider	Buy	5,000	$26.93	$134,650.00	16,527
11/2/2023	Yajing Chen	CFO	Sell	165	$25.23	$4,162.95	6,982
3/6/2023	Frazor Titus Edmondson, III	Insider	Sell	7,965	$40.55	$322,980.75	19,400
3/3/2023	Harald Reinhart	Insider	Sell	11,480	$40.00	$459,200.00	18,958
3/3/2023	William Lis	Director	Sell	5,434	$38.31	$208,176.54	23,330
11/15/2022	Harald Reinhart	Insider	Sell	1,854	$40.00	$74,160.00	24,861
2/4/2022	John D. Diekman	Director	Sell	1,000	$50.17	$50,170.00
1/20/2022	William Lis	Director	Sell	1,926	$53.40	$102,848.40
12/8/2021	Peter Wirth	Director	Buy	4,000	$71.36	$285,440.00

Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners

From Colonial Metals | Ad

Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…

Get Your Free Gold Guide

SEC Filings (Institutional Ownership Changes) for Zai Lab (NASDAQ:ZLAB)

41.65% of Zai Lab stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Zai Lab Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/16/2024	Geode Capital Management LLC	43,626	$1.05M	0.0%	+26.4%	0.044%
11/15/2024	M&T Bank Corp	25,188	$0.61M	0.0%	+9.6%	0.025%
11/15/2024	Public Employees Retirement System of Ohio	15,301	$0.37M	0.0%	N/A	0.015%
11/15/2024	Y Intercept Hong Kong Ltd	9,339	$0.23M	0.0%	N/A	0.009%
11/15/2024	XTX Topco Ltd	31,618	$0.76M	0.1%	+8.0%	0.032%
11/15/2024	Wellington Management Group LLP	8,436,606	$203.66M	0.0%	+18.4%	8.470%
11/15/2024	State Street Corp	153,455	$3.70M	0.0%	-5.0%	0.154%
11/15/2024	Quantinno Capital Management LP	9,631	$0.23M	0.0%	-28.3%	0.010%
11/15/2024	RBF Capital LLC	10,000	$0.24M	0.0%	N/A	0.010%
11/15/2024	Point72 Asset Management L.P.	13,464	$0.33M	0.0%	N/A	0.014%
11/15/2024	Janus Henderson Group PLC	8,760,074	$211.49M	0.1%	+34.2%	8.794%
11/15/2024	Bamco Inc. NY	1,906,520	$46.02M	0.1%	+6.4%	1.914%
11/15/2024	Erste Asset Management GmbH	15,100	$0.36M	0.0%	N/A	0.015%
11/14/2024	PEAK6 Investments LLC	16,000	$0.39M	0.0%	N/A	0.016%
11/13/2024	BNP Paribas Financial Markets	1,283	$31K	0.0%	-80.5%	0.001%
11/13/2024	FMR LLC	644,859	$15.57M	0.0%	-43.0%	0.647%
11/13/2024	The Manufacturers Life Insurance Company	121,084	$2.92M	0.0%	+3.3%	0.122%
11/13/2024	Daiwa Securities Group Inc.	9,557	$0.23M	0.0%	+4,851.8%	0.010%
11/12/2024	Algert Global LLC	69,000	$1.67M	0.0%	N/A	0.069%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	604,153	$14.58M	0.1%	+26.2%	0.607%
10/25/2024	China Universal Asset Management Co. Ltd.	9,559	$0.23M	0.0%	+58.1%	0.010%
10/24/2024	DekaBank Deutsche Girozentrale	36,648	$0.90M	0.0%	+22.2%	0.037%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	4,517	$0.11M	0.0%	-94.8%	0.005%
10/23/2024	Hennion & Walsh Asset Management Inc.	142,189	$3.43M	0.2%	+14.6%	0.143%
8/27/2024	Clearbridge Investments LLC	792,815	$13.74M	0.0%	-2.4%	0.796%
8/15/2024	The Manufacturers Life Insurance Company	117,224	$2.03M	0.0%	+18.9%	0.118%
8/15/2024	AXA S.A.	65,814	$1.14M	0.0%	-12.2%	0.066%
8/13/2024	DCF Advisers LLC	30,450	$0.53M	0.3%	N/A	0.031%
8/12/2024	XTX Topco Ltd	29,283	$0.51M	0.0%	+19.2%	0.029%
8/9/2024	Renaissance Technologies LLC	28,214	$0.49M	0.0%	+91.9%	0.028%
8/9/2024	Dimensional Fund Advisors LP	15,555	$0.27M	0.0%	N/A	0.016%
8/8/2024	DekaBank Deutsche Girozentrale	30,000	$0.52M	0.0%	-18.1%	0.030%
8/7/2024	Headlands Technologies LLC	1,612	$28K	0.0%	-59.4%	0.002%
8/6/2024	Candriam S.C.A.	365,013	$6.33M	0.0%	-31.8%	0.366%
8/3/2024	TD Asset Management Inc	221,970	$3.85M	0.0%	+1.4%	0.223%
8/1/2024	Privium Fund Management B.V.	215,789	$3.75M	1.0%	-10.3%	0.217%
7/20/2024	Hennion & Walsh Asset Management Inc.	124,096	$2.15M	0.1%	+96.5%	0.125%
7/16/2024	M&G Plc	437,265	$7.43M	0.0%	-3.7%	0.439%
6/4/2024	DekaBank Deutsche Girozentrale	36,648	$0.59M	0.0%	-45.0%	0.037%
5/21/2024	Swedbank AB	15,200	$0.24M	0.0%	N/A	0.015%
5/17/2024	Tidal Investments LLC	20,858	$0.33M	0.0%	N/A	0.021%
5/16/2024	Janus Henderson Group PLC	4,428,011	$70.92M	0.0%	+9.6%	4.463%
5/15/2024	Bamco Inc. NY	1,599,865	$25.63M	0.1%	+7.3%	1.613%
5/15/2024	Price T Rowe Associates Inc. MD	1,650,787	$26.45M	0.0%	-39.0%	1.664%
5/14/2024	Capital World Investors	5,684,180	$91.06M	0.0%	+8.9%	5.730%
5/14/2024	Capital International Inc. CA	92,108	$1.48M	0.0%	+6.7%	0.093%
5/13/2024	Clearbridge Investments LLC	812,579	$13.02M	0.0%	-1.3%	0.819%
5/10/2024	M&G Plc	454,128	$7.27M	0.0%	N/A	0.458%
5/8/2024	Russell Investments Group Ltd.	293,783	$4.71M	0.0%	+51.1%	0.296%
5/8/2024	Headlands Technologies LLC	3,971	$64K	0.0%	N/A	0.004%
5/3/2024	GSA Capital Partners LLP	45,573	$0.73M	0.1%	+313.5%	0.046%
5/1/2024	BNP Paribas Financial Markets	2,671	$43K	0.0%	+51.2%	0.003%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	104,282	$1.81M	0.0%	-8.9%	0.105%
4/29/2024	China Universal Asset Management Co. Ltd.	9,530	$0.15M	0.0%	+64.3%	0.010%
4/22/2024	Vivo Capital LLC	531,198	$8.51M	0.7%	+29.0%	0.535%
4/17/2024	Hennion & Walsh Asset Management Inc.	63,169	$1.01M	0.1%	+35.8%	0.064%
3/27/2024	Nomura Holdings Inc.	10,067	$0.28M	0.0%	-79.1%	0.010%
3/5/2024	Wellington Management Group LLP	5,336,457	$145.85M	0.0%	+177.6%	5.399%
2/14/2024	ADAR1 Capital Management LLC	20,000	$0.55M	0.2%	N/A	0.020%
2/14/2024	Bellevue Group AG	135,000	$3.71M	0.1%	N/A	0.137%
2/14/2024	Sectoral Asset Management Inc.	4,000	$0.11M	0.0%	+33.3%	0.004%
2/14/2024	Brilliance Asset Management Ltd.	435,926	$11.91M	2.6%	+177.5%	0.441%
2/13/2024	Tower Research Capital LLC TRC	2,550	$70K	0.0%	+1,923.8%	0.003%
2/13/2024	Capital International Investors	806,453	$22.04M	0.0%	-4.6%	0.816%
2/13/2024	Campbell & CO Investment Adviser LLC	15,795	$0.43M	0.0%	N/A	0.016%
2/12/2024	Allianz Asset Management GmbH	679,524	$18.57M	0.0%	+26.1%	0.687%
2/12/2024	TD Asset Management Inc	235,570	$6.44M	0.0%	+8.6%	0.238%
2/12/2024	Hsbc Holdings PLC	57,348	$1.57M	0.0%	-82.5%	0.058%
2/9/2024	Trexquant Investment LP	20,917	$0.57M	0.0%	N/A	0.021%
2/8/2024	Kingsview Wealth Management LLC	7,396	$0.20M	0.0%	N/A	0.007%
2/8/2024	Baader Bank Aktiengesellschaft	9,284	$0.25M	0.0%	N/A	0.009%
2/8/2024	M&G Investment Management Ltd.	457,727	$12.36M	0.1%	-2.0%	0.463%
2/7/2024	Segantii Capital Management Ltd	1,687,569	$46.47M	2.5%	-5.7%	1.707%
2/7/2024	Vivo Capital LLC	411,677	$11.25M	0.9%	-9.4%	0.417%
2/5/2024	RWC Asset Management LLP	8,326	$0.23M	0.0%	N/A	0.008%
2/5/2024	Russell Investments Group Ltd.	194,428	$5.31M	0.0%	-2.1%	0.197%
2/1/2024	New York State Common Retirement Fund	33,548	$0.92M	0.0%	+4,470.6%	0.034%
2/1/2024	Handelsbanken Fonder AB	68,685	$1.88M	0.0%	-27.4%	0.069%
1/30/2024	Genesis Investment Management LLP	692,663	$18.93M	3.7%	-32.9%	0.701%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	114,418	$3.13M	0.0%	-5.9%	0.116%
1/24/2024	China Universal Asset Management Co. Ltd.	5,802	$0.16M	0.0%	+323.2%	0.006%
1/16/2024	Raymond James & Associates	13,674	$0.37M	0.0%	-27.6%	0.014%
1/12/2024	SG Americas Securities LLC	4,241	$0.12M	0.0%	N/A	0.004%
12/1/2023	Wellington Management Group LLP	1,922,628	$46.74M	0.0%	-7.4%	1.945%
11/22/2023	Polar Capital Holdings Plc	114,536	$2.78M	0.0%	-36.8%	0.116%
11/15/2023	WealthPlan Investment Management LLC	39,393	$0.96M	0.1%	+81,968.8%	0.040%
11/15/2023	Rock Springs Capital Management LP	1,237,023	$30.07M	0.8%	+1.2%	1.252%
11/15/2023	Sectoral Asset Management Inc.	3,000	$73K	0.0%	-62.5%	0.003%
11/15/2023	Lansdowne Partners UK LLP	35,142	$0.85M	0.1%	N/A	0.036%
11/15/2023	Alps Advisors Inc.	72,842	$1.77M	0.0%	+3.2%	0.074%
11/14/2023	Nomura Holdings Inc.	48,067	$1.17M	0.0%	N/A	0.049%
11/14/2023	Bamco Inc. NY	1,579,349	$38.39M	0.1%	+4.5%	1.598%
11/14/2023	Profund Advisors LLC	19,777	$0.48M	0.0%	+4.9%	0.020%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	182,786	$4.44M	0.0%	-19.3%	0.185%
11/13/2023	Clearbridge Investments LLC	822,888	$20M	0.0%	+1.4%	0.833%
11/13/2023	Hsbc Holdings PLC	327,781	$7.97M	0.0%	+251.1%	0.332%
11/13/2023	Invesco Ltd.	3,209,303	$78.02M	0.0%	-11.2%	3.247%
11/13/2023	FMR LLC	1,268,202	$30.83M	0.0%	-35.8%	1.283%
11/13/2023	Atika Capital Management LLC	32,000	$0.78M	0.1%	-77.9%	0.032%
11/13/2023	PNC Financial Services Group Inc.	1,896	$46K	0.0%	+58.5%	0.002%

Data available starting January 2016

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commercial products include Zejula, an orally administered poly polymerase 1/2 inhibitor; Optune, a cancer therapy that uses electric fields tuned to specific frequencies to kill tumor cells; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; Qinlock to treat gastrointestinal stromal tumors, and VYVGART, a human IgG1 antibody fragment for myesthenia gravis. The company also develops Tumor Treating Fields, a portable device for delivery of electric fields; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer patients; Tisotumab vedotin, an antibody drug conjugate; Adagrasib for treating KRAS-G12C-mutated NSCLC, colorectal cancer, and pancreatic cancer; and Bemarituzumab to treat gastric and gastroesophageal junction cancer patients. In addition, it develops Sulbactam/durlobactam, a combination of a beta-lactam antibiotic and a beta-lactamase inhibitor for the treatment of serious infections caused by Acinetobacter; KarXT for the treatment of psychiatric and neurological conditions. It has license and collaboration agreement with Tesaro, Inc. to develop, manufacture, and commercialize niraparib; NovoCure to develop and commercialize Tumor Treating Fields; Deciphera to develop and commercialize ripretinib; Paratek Bermuda Ltd. to develop, manufacture, and commercialize omadacycline; argenx, to develop and commercialize efgartigimod; BMS to develop and commercialize tisotumab vedotin and repotrectinib; Mirati to research, develop, manufacture, and commercialize adagrasib; Amgen to develop and commercialize bemarituzumab; and Innoviva to develop and commercialize Sulbactam-Durlobactam; Karuna to develop and commercialize KarXT. The company was incorporated in 2013 and is headquartered in Shanghai, China.

Today's Range

Now: $26.23

$25.63

$26.77

50 Day Range

MA: $26.28

$20.34

$33.18

52 Week Range

Now: $26.23

$13.48

$36.60

Volume

1,384,654 shs

Average Volume

1,308,194 shs

Market Capitalization

$2.61 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.04

Who are the company insiders with the largest holdings of Zai Lab?: Zai Lab's top insider shareholders include:
Ying Du (CEO)
Harald Reinhart (Insider)
William Lis (Director)
Joshua L Smiley (Insider)
Rafael Amado (Insider)
Frazor Titus Edmondson III (Insider)
Yajing Chen (CFO)
Learn More about top insider investors at Zai Lab.
Who are the major institutional investors of Zai Lab?: Zai Lab's top institutional shareholders include:
Janus Henderson Group PLC — 8.79%
Wellington Management Group LLP — 8.47%
Bamco Inc. NY — 1.91%
FMR LLC — 0.65%
Connor Clark & Lunn Investment Management Ltd. — 0.61%
Jane Street Group LLC — 0.00%
Learn More about top institutional investors of Zai Lab stock.
Which major investors are selling Zai Lab stock?: Within the previous quarter, ZLAB stock was sold by these institutional investors:
FMR LLC
Jane Street Group LLC
Mirae Asset Global Investments Co. Ltd.
State Street Corp
BNP Paribas Financial Markets
Quantinno Capital Management LP
During the previous year, company insiders that have sold Zai Lab company stock include:
Ying Du (CEO)
Harald Reinhart (Insider)
William Lis (Director)
Joshua L Smiley (Insider)
Rafael Amado (Insider)
Frazor Titus Edmondson III (Insider)
Yajing Chen (CFO)
Learn More investors selling Zai Lab stock.
Which major investors are buying Zai Lab stock?: Within the previous quarter, ZLAB stock was bought by institutional investors including:
Janus Henderson Group PLC
Wellington Management Group LLP
Connor Clark & Lunn Investment Management Ltd.
Bamco Inc. NY
Algert Global LLC
Hennion & Walsh Asset Management Inc.
PEAK6 Investments LLC
Public Employees Retirement System of Ohio